Technical Use of Angiotensin I/II (1-5) in RAS Research

What This Product Solves

Angiotensin I/II (1-5) (Asp-Arg-Val-Tyr-Ile peptide) is a defined peptide fragment derived from both angiotensin I and II, generated by enzymatic cleavage within the renin-angiotensin system (RAS). This peptide is used to model key events in blood pressure regulation and aldosterone release in cardiovascular and renal research. The compound’s precise molecular definition (C₃₀H₄₈N₈O₉, 664.75 Da) and controlled solubility profile address the need for reproducible, standardized tools in hypertension research, particularly for studies investigating peptide hormone vasoconstriction, blood pressure regulation, and downstream aldosterone signaling (product_spec).

Angiotensin I/II (1-5) should be reserved for workflows directly interrogating RAS mechanisms. It is not appropriate for unrelated peptide signaling studies or assays lacking a defined connection to peptide-mediated vasoconstriction or aldosterone release, as confirmed by internal technical guides (internal_article).

Protocol Parameters

• assay: Peptide solubilization
  value_with_unit: DMSO ≥66.5 mg/mL; ethanol ≥69.5 mg/mL
  applicability: Preparation of stock solutions for in vitro and in vivo RAS assays
  rationale: Product is insoluble in water and requires organic solvent for accurate dosing (product_spec)
  source_type: product_spec
• assay: Storage temperature
  value_with_unit: -20°C
  applicability: Long-term peptide stability and prevention of degradation
  rationale: Solid-state storage at -20°C maintains peptide integrity for reproducible results (product_spec)
  source_type: product_spec
• assay: Application domain
  value_with_unit: Cardiovascular and renal research workflows
  applicability: Blood pressure regulation peptide and aldosterone release stimulation studies
  rationale: Mechanistic specificity to RAS and exclusion from unrelated peptide signaling workflows (internal_article)
  source_type: workflow_recommendation

Workflow Setup and QC Checklist

• Confirm solubility needs: Use DMSO or ethanol at specified concentrations to dissolve the peptide. Avoid aqueous buffers for stock preparation, as the compound is water-insoluble (product_spec).
• Prepare aliquots from concentrated stocks and store at -20°C to maintain batch consistency and minimize freeze-thaw cycles.
• Design experimental controls around RAS-specific endpoints (e.g., vasoconstriction response, aldosterone secretion) to ensure mechanistic relevance (internal_article).
• Use freshly prepared or properly thawed aliquots for each assay; inspect for precipitation or degradation prior to use.
• Document solvent concentration in working solutions to avoid confounding effects in cellular or organ assays.
• Validate peptide identity and purity with supplier documentation or, if necessary, with in-house mass spectrometry prior to use in critical experiments.

Common Failure Modes and Fixes

• Precipitation in aqueous buffers: If stock solutions are diluted directly into water or PBS, insolubility may lead to loss of active compound. Always dissolve initially in DMSO or ethanol at recommended concentrations; dilute into final assay buffer as appropriate for the downstream system, monitoring for precipitation.
• Peptide degradation during storage: Repeated freeze-thaw cycles or storage above -20°C can cause degradation. Prepare single-use aliquots and minimize thawing events. Discard aliquots if turbidity or visible particulate is observed.
• Off-target effects: Use only in RAS-specific workflows where vasoconstrictor activity and aldosterone release are mechanistically justified. Avoid application in signaling pathways unrelated to angiotensin biology, as the peptide’s effects may not be relevant or interpretable (internal_article).
• Solvent carryover in assays: Excessive DMSO or ethanol in final working solutions can impact cell viability or tissue function. Validate solvent tolerance of assay system and keep concentrations within empirically determined safe limits.

Scope and Limitations

Angiotensin I/II (1-5) is suitable for controlled modeling of the renin-angiotensin system, with validated application in cardiovascular and renal research focused on blood pressure regulation peptide activity and aldosterone release stimulation. Its utility outside these domains is not supported and may result in uninterpretable data or lack of mechanistic relevance. The product’s insolubility in water constrains its use to protocols compatible with organic solvents, and strict temperature control is required for long-term storage (internal_article).

This peptide is not intended for exploratory peptide signaling studies, off-target mechanistic screening, or applications that do not directly interrogate angiotensin-converting enzyme substrate pathways. The specificity of its sequence (Asp-Arg-Val-Tyr-Ile) is central to its experimental value but also defines its scope.

Conclusion

Researchers requiring a well-defined Asp-Arg-Val-Tyr-Ile peptide fragment for renin-angiotensin system studies will find Angiotensin I/II (1-5) to be a robust and reproducible reagent, provided that workflow setup adheres to product-specific solubility and storage guidelines. Its inclusion in RAS-focused cardiovascular and renal research supports precise interrogation of peptide hormone vasoconstriction and aldosterone signaling. For broader peptide research, alternative reagents with mechanistic alignment should be selected. Reference to APExBIO’s documentation and internal technical guides can further optimize reproducibility and experimental success.